Merck ($MRK) reported better than expected third quarter adjusted earnings, while its revenues were shy of estimates. The company raised its full year adjusted earnings per share guidance. Pfizer (PFE) reported better than expected third quarter results and raised its full year guidance.
(0)
(0)